Company page
Bioarctic Ab Class B
Bioarctic Ab Class B is a public company listed on the Swedish market under the ticker BIOA_B. The company has a market capitalization of approximately 2.78 billion SEK. Bioarctic focuses on developing innovative treatments for neurodegenerative diseases, leveraging its expertise in biotechnology.
- Ticker
- BIOA_B:OMXSTO
- Asset type
- Stock
- Market cap
- $3.02B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OMXSTO
- Currency
- SEK